Cited by 4,649Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, Lawrence A., Harvey, Michele, Slagle, Betty L., McArthur, Mark J., Montgomery, Charles A., Butel, Janet S., Bradley, Allan·1992·Nature

DOI 10.1038/356215a0

Open this paper in CoChat — free account

Abstract

Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.

Integrity signals

Registry

Crossref · 10.1038/356215a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997
Self-citation
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683

Show all 48 references

Research works printed but not linked: 10

Mowat, M., Cheng, A., Kicumca, N., Bernstein, A. & Benchimol, S. Nature 61, 2777–2781 (1985).
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S. & Bernstein, A. Oncogene 3, 179–185 (1988).
Stürzbecher, H.-W. et al. Oncogene 5, 795–801 (1990).
Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. Oncogene 5, 1707–1711 (1990).
Soussi, T., de Fromentel, C. C. & May, P. Oncogene 5, 945–952 (1990).
Bradley, A. in Tetratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Stutman, O. Fed. Proc. Fed. Am. Soc. exp. Biol. 33, 2028–2032 (1974).
Yandell, D. W. Proc. Am. Assoc. Cancer Res. 32, 459–460 (1991).
Sepulveda, A. R. et al. Cancer Res. 49, 6108–6117 (1989).
Slagle, B. L., Lanford, R. E., Medina, D. & Butel, J. S. Cancer Res. 42, 2155–2162 (1984).

Sorted by citations

Items 801–900 of 1,032

Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation
Katiyar, S. K., Roy, A. M., & Baliga, M. S. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.207.4.2 · Cited by 139
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformationPreprint
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 139
p53: The Attractive Tumor Suppressor in the Cancer Research Field
Ozaki, T., & Nakagawara, A. (2010) · BioMed Research International · doi:10.1155/2011/603925 · Cited by 138
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network
Lefort, K., Brooks, Y., Ostano, P., Cario, M., Calpini, V., Guinea‐Viniegra, J., Albinger‐Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E. F., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.156 · Cited by 138
Mouse Tumor Models for Advanced Cancer Immunotherapy
Chulpanova, D. S., Kitaeva, K. V., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114118 · Cited by 138
Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo
Burns, T. F., Bernhard, E. J., & El‐Deiry, W. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204484 · Cited by 138
Interaction of heat‐shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation.
Hainaut, P. L., & Milner, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05434.x · Cited by 138
The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
McLaughlin, S. K., Olsen, S. N., Dake, B. T., Raedt, T. D., Lim, E., Bronson, R. T., Beroukhim, R., Polyák, K., Brown, M. A., Kuperwasser, C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.004 · Cited by 137
Genetic Background and the Dilemma of Translating Mouse Studies to Humans
Rivera, J., & Tessarollo, L. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.008 · Cited by 137
Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes
Amsterdam, A., & Selvaraj, N. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0306 · Cited by 137
Aneuploidy, the Primary Cause of the Multilateral Genomic Instability of Neoplastic and Preneoplastic Cells
DUESBERG, P. H., Fabarius, A. C., & Hehlmann, R. (2004) · IUBMB Life · doi:10.1080/15216540410001667902 · Cited by 136
Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers
Nicholls, C. D., McLure, K. G., Shields, M. A., & Lee, P. W. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108815200 · Cited by 136
The control of hematopoiesis and leukemia: from basic biology to the clinic.
Sachs, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4742 · Cited by 136
Identification and functional characterization of two new transcriptional variants of the human p63 gene
Mangiulli, M., Valletti, A., Caratozzolo, M. F., Tullo, A., Sbisà, E., Pesole, G., & D’Erchia, A. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp674 · Cited by 135
Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice
TeKippe, M., Harrison, D. E., & Chen, J. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00072-9 · Cited by 135
ASPPs and cancer
Trigiante, G., & Lü, X. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1818 · Cited by 135
Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss, A., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1997) · PubMed · Cited by 135
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool
Luo, J., Yang, Q., Tong, W., Hergenhahn, M., Wang, Z., & Hollstein, M. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204080 · Cited by 135
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao, M., Low, J., Dorn, E., Ku, D., Pattengale, P. K., Yeargin, J., & Haas, M. (1994) · PubMed Central · Cited by 135
Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders
Glickman, J. N., Yang, A., Shahsafaei, A., McKeon, F., & Odze, R. D. (2001) · Human Pathology · doi:10.1053/hupa.2001.28951 · Cited by 135
p53 Tumor Suppressor Gene: At the Crossroads of Molecular Carcinogenesis, Molecular Epidemiology, and Cancer Risk Assessment
Harris, C. C. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3435 · Cited by 135
The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality
Johnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 134
Expression of the p53 Homologue p63 in Early Cervical Neoplasia
Quade, B. J., Yang, A., Wang, Y., Sun, D., Park, J.-J., Sheets, E. E., Čviko, A., Federschneider, J. M., Peters, R., McKeon, F., et al. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.5953 · Cited by 134
Requirement of ATM in Phosphorylation of the Human p53 Protein at Serine 15 following DNA Double-Strand Breaks
Nakagawa, K., Taya, Y., Tamai, K., & Yamaizumi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2828 · Cited by 134
Molecular and Cellular Events in Early Thymocyte Development 11Received for publication October 14, 1997
Rodewald, H.-R., & Fehling, H. J. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60606-9 · Cited by 134
Dietary restriction improves repopulation but impairs lymphoid differentiation capacity of hematopoietic stem cells in early aging
Tang, D., Tao, S., Chen, Z., Koliesnik, I. O., Calmes, P. G., Hoerr, V., Han, B., Gebert, N., Zörnig, M., Löffler, B., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151100 · Cited by 133
Genome instability, cancer and aging
Maslov, A. Y., & Vijg, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.020 · Cited by 134
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 133
The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway
MacLaine, N. J., & Hupp, T. R. (2009) · Aging · doi:10.18632/aging.100047 · Cited by 134
Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis
Iozzo, R. V., Chakrani, F., Perrotti, D., McQuillan, D. J., Skórski, T., Calabretta, B., & Eichstetter, I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3092 · Cited by 133
Functional Interaction of H2AX, NBS1, and p53 in ATM-Dependent DNA Damage Responses and Tumor Suppression
Kang, J., Ferguson, D. O., Song, H., Bassing, C. H., Eckersdorff, M., Alt, F. W., & Xu, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.661-670.2005 · Cited by 133
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice
Jolly, C. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.10.1913 · Cited by 133
Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
Basu, A., & Pal, D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.214 · Cited by 132
p53 and Tumor Necrosis Factor α Regulate the Expression of a Mitochondrial Chloride Channel Protein
Fernández‐Salas, E., Sagar, M., Cheng, C., Yuspa, S. H., & Weinberg, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36488 · Cited by 132
Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids
Chojkier, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00231-9 · Cited by 132
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease
McDonald, D. A., Shenkar, R., Shi, C., Stockton, R. A., Akers, A. L., Kucherlapati, M. H., Kucherlapati, R., Brainer, J., Ginsberg, M. H., Awad, I. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq433 · Cited by 132
Modeling human lung cancer in mice: similarities and shortcomings
Tuveson, D. A., & Jacks, T. (1999) · Oncogene · doi:10.1038/sj.onc.1203107 · Cited by 132
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon, R. Y. C., Chau, M. S., Yamashita, K., & Hunter, T. R. (1997) · PubMed · Cited by 132
The role of interferon regulatory factors in the interferon system and cell growth control
Harada, H., Taniguchi, T., & Tanaka, N. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80017-0 · Cited by 132
ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation
Lü, X., Park, S. H., Thompson, T. C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90541-j · Cited by 132
Increased Sensitivity of Human Vascular Smooth Muscle Cells From Atherosclerotic Plaques to p53-Mediated Apoptosis
Bennett, M. R., Littlewood, T. D., Schwartz, S. M., & Weissberg, P. L. (1997) · Circulation Research · doi:10.1161/01.res.81.4.591 · Cited by 132
Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis
Hussain, S. P., Trivers, G. E., Hofseth, L. J., He, P., Shaikh, I. A., Mechanic, L. E., Doja, S., Jiang, W., Subleski, J. J., Shorts, L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2201 · Cited by 131
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 131
The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiationPreprint
Liu, H., Wang, Y., Belz, T., Bock, D., Takacs, A., Radlwimmer, B., Barbus, S., Reifenberger, G., Lichter, P., & Schütz, G. (2010) · Genes & Development · doi:10.1101/gad.560310 · Cited by 131
Muscle cachexia is regulated by a p53–PW1/Peg3-dependent pathwayPreprint
Schwarzkopf, M., Coletti, D., Sassoon, D. A., & Marazzi, G. (2006) · Genes & Development · doi:10.1101/gad.412606 · Cited by 131
p53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 130
Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomas
Wakabayashi, Y., Inoue, J., Takahashi, Y., Matsuki, A., Kosugi-Okano, H., Shinbo, T., Mishima, Y., Niwa, O., & Kominami, R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03069-3 · Cited by 130
Evolution of Functions within the p53/p63/p73 Family
Laurenzi, V. D., & Melino, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05602.x · Cited by 130
Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens
Tennant, R. W., Spalding, J. W., & French, J. E. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90016-0 · Cited by 130
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Pant, V., Quintás-Cardama, A., & Lozano, G. (2012) · Blood · doi:10.1182/blood-2012-05-356014 · Cited by 129
p53 regulates the cardiac transcriptome
Mak, T. W., Hauck, L., Grothe, D., & Billia, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621436114 · Cited by 129
Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson, J. W., Deed, R. W., Inoue, T., Balzi, M., Becciolini, A., Faraoni, P., Potten, C. S., & Norton, J. D. (2001) · PubMed · Cited by 129
Estrogen receptor corepressors -- a role in human breast cancer?
Dobrzycka, K. M., Townson, S. M., Jiang, S., & Oesterreich, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100517 · Cited by 129
Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis
Smith, M. L., & Fornace, A. J. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90043-3 · Cited by 129
Interference with p53 protein inhibits hematopoietic and muscle differentiation.
Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M. G., Bossi, G., Cimino, L., Crescenzi, M., & Sacchi, A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.1.193 · Cited by 129
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformationPreprint
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 129
A mouse model of human oral-esophageal cancer
Opitz, O. G., Harada, H., Suliman, Y., Rhoades, B., Sharpless, N. E., Kent, R., Kopelovich, L., Nakagawa, H., & Rustgi, A. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15324 · Cited by 128
Classic and novel roles of p53: prospects for anticancer therapy
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 128
Trp53-dependent DNA-repair is affected by the codon 72 polymorphism
Siddique, M. M., & Sabapathy, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209405 · Cited by 128
Death-defying acts: a meeting review on apoptosis.Preprint
White, E. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2277 · Cited by 128
P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development
Bowling, S., Gregorio, A. D., Sancho, M., Pozzi, S., Aarts, M., Signore, M., Schneider, M. D., Martı́nez-Barberá, J. P., Gil, J., & Rodríguez, T. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04167-y · Cited by 127
p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation
Schüler, M., Maurer, U., Goldstein, J. C., Breitenbücher, F., Hoffarth, S., Waterhouse, N. J., & Green, D. R. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401180 · Cited by 127
Targeting signal transduction pathways by chemopreventive agents
Bode, A. M., & Dong, Z. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.018 · Cited by 127
p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop
Kartasheva, N. N., Contente, A., Lenz-Stöppler, C., Roth, J. C., & Dobbelstein, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205584 · Cited by 127
Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
Burns, J. E., Baird, M., Clark, L., Burns, P. A., Edington, K. G., Chapman, C., Mitchell, R. T., Robertson, G., Soutar, D. S., & Parkinson, E. K. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.238 · Cited by 127
Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.
Souza, R. F., Yin, J., Smolinski, K. N., Zou, T., Wang, S., Shi, Y. Q., Rhyu, M. G., Cottrell, J. R., Abraham, J. M., Biden, K. G., et al. (1997) · PubMed · Cited by 127
pRb and the Cdks in apoptosis and the cell cycle
Kasten, M. M., & Giordano, A. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400323 · Cited by 127
c-MYC-Induced Genomic InstabilityPreprint
Kuzyk, R., & Mai, S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014373 · Cited by 127
Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
Guo, S., Ye, H., Teng, Y., Wang, Y.-L., Yang, G., Li, X.-B., Zhang, C., Yang, X., Yang, Z., & Yang, X. Y. (2013) · Nature Communications · doi:10.1038/ncomms3544 · Cited by 126
Apoptosis at the time of embryo implantation in mouse and rat
Pampfer, S., & Donnay, I. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400516 · Cited by 126
Different impact of p53 and p21 on the radiation response of mouse tissues
Komarova, E. A., Christov, K. T., Faerman, A., & Gudkov, A. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203717 · Cited by 126
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Swann, J. B., Uldrich, A. P., van Dommelen, S. L. H., Sharkey, J., Murray, W. K., Godfrey, D. I., & Smyth, M. J. (2009) · Blood · doi:10.1182/blood-2009-01-198564 · Cited by 126
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
Zhao, L., Samuels, T. L., Winckler, S., Korgaonkar, C. K., Tompkins, V. S., Horne, M. C., & Quelle, D. E. (2003) · PubMed · Cited by 126
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells
Antonini, D., Russo, M. T., Rosa, L. D., Gorrese, M., Vecchio, L. D., & Missero, C. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.438 · Cited by 125
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125
Treacher Collins syndrome: Unmasking the role of Tcof1/treacle
Sakai, D., & Trainor, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.026 · Cited by 125
Role of Human Cytomegalovirus Immediate-Early Proteins in Cell Growth Control
Castillo, J., Yurochko, A. D., & Kowalik, T. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8028-8037.2000 · Cited by 125
The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
Pritchard, D. M., Potten, C. S., & Hickman, J. A. (1998) · PubMed · Cited by 125
T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage‐induced cell death in the absence of p53.
Brady, H. J. M., Salomons, G. S., Bobeldijk, R. C., & Berns, A. J. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00463.x · Cited by 125
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Santoro, F., Botrugno, O. A., Zuffo, R. D., Pallavicini, I., Matthews, G. M., Cluse, L. A., Barozzi, I., Senese, S., Fornasari, L., Moretti, S., et al. (2013) · Blood · doi:10.1182/blood-2012-10-461988 · Cited by 124
Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction
Gollner, A., Rudolph, D., Arnhof, H., Bauer, M., Blake, S. M., Boehmelt, G., Cockroft, X.-L., Dahmann, G., Ettmayer, P., Gerstberger, T., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00900 · Cited by 124
Regulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B. M. R., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 124
Expression and Activity of L-Myc in Normal Mouse Development
Hatton, K. S., Mahon, K., Chin, L., Chiu, F., Lee, H., Peng, D., Morgenbesser, S. D., Horner, J. W., & DePinho, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1794 · Cited by 124
P53 Regulates Myogenesis by Triggering the Differentiation Activity of Prb
Porrello, A., Cerone, M. A., Coen, S., Gurtner, A., Fontemaggi, G., Cimino, L., Piaggio, G., Sacchi, A., & Soddu, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1295 · Cited by 124
Asymmetric Cell Kinetics Genes: The Key to Expansion of Adult Stem Cells in Culture
Sherley, J. L. (2002) · Stem Cells · doi:10.1634/stemcells.20-6-561 · Cited by 124
Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene
Tao, Q., Fujimoto, J., Men, T., Ye, X., Deng, J., Lacroix, L., Clifford, J. L., Mao, L., Pelt, C. S. V., Lee, J. J., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm208 · Cited by 124
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation
Griep, A. E., Herber, R., Jeon, S., Lohse, J. K., Dubielzig, R. R., & Lambert, P. F. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1373-1384.1993 · Cited by 124
Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
Li, C. J., Wang, C., Friedman, D. J., & Pardee, A. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5461 · Cited by 124
Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
Leibowitz, B. J., Qiu, W., Liu, H., Cheng, T., Zhang, L., & Yu, J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0052 · Cited by 123
p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival
Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 124
Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis
Lin, S. J., Lee, K., Nikitin, A. Y., Hilsenbeck, S. G., Cardiff, R. D., Li, A., Kang, K.-W., Frank, S. A., Lee, W., & Lee, E. Y.-H. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3524 · Cited by 123
DNA Strand Break-Sensing Molecule Poly(ADP-Ribose) Polymerase Cooperates with p53 in Telomere Function, Chromosome Stability, and Tumor Suppression
Tong, W., Hande, M. P., Lansdorp, P. M., & Wang, Z. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4046-4054.2001 · Cited by 123
Common Regulation of Growth Arrest and Differentiation of Osteoblasts by Helix-Loop-Helix Factors
Funato, N., Ohtani, K., Ohyama, K., Kuroda, T., & Nakamura, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7416-7428.2001 · Cited by 123
Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons.
Slack, R. S., Belliveau, D. J., Rosenberg, M., Atwal, J. K., Lochmüller, H., Aloyz, R. S., Haghighi, A. P., Lach, B., Seth, P. K., Cooper, E. A., et al. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.1085 · Cited by 123
Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53Preprint
Nozawa, H., Oda, E., Nakao, K., Ishihara, M., Ueda, S., Yokochi, T., Ogasawara, K., Nakatsuru, Y., SHIMIZU, S., Ohira, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.10.1240 · Cited by 123
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
p53-Dependent Translational Control of Senescence and Transformation via 4E-BPs
Petroulakis, E., Parsyan, A. E., Dowling, R. J. O., Bacquer, O. L., Martineau, Y., Bidinosti, M., Larsson, O. S., Alain, T., Rong, L., Mamane, Y., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.025 · Cited by 122
Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53
Chen, R., Saunders, P. A., Wei, H., Li, Z., Seth, P. K., & Chuang, D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09654.1999 · Cited by 122

Authors: Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A.
Affiliations: Baylor College of Medicine (US)
ORCID: Slagle, Betty L.
Butel, Janet S.
Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1992-03
Volume: 356
Issue: 6366
Pages: 215-221
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/356215a0
OpenAlex: W2126679757
Cited by: 4,649
References: 48
Citations by year: 2026: 16 · 2025: 48 · 2024: 51 · 2023: 74 · 2022: 76 · 2021: 80 · 2020: 86 · 2019: 92 · 2018: 84 · 2017: 96 · 2016: 119 · 2015: 89 · 2014: 121 · 2013: 146 · 2012: 157
FWCI: 82.13
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, spontaneous tumors, carcinogenesis, embryonic development, mouse model, neoplasms
MeSH terms: Alleles, Animals, Base Sequence, Blastocyst, DNA, Exons, Female, Genetic Vectors, Heterozygote, Homozygote, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mutation, Neoplasms, Experimental, RNA, Messenger, Stem Cells, Blotting, Southern, Polymerase Chain Reaction, Genes, p53, Tumor Suppressor Protein p53, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks